European Partnership on One Health Antimicrobial Resistance
European Commission
Research & Innovation call 2025
The first EUP OHAMR joint transnational call will be within the focus area of providing innovative and cost-effective treatment options. The call will be launched in November 2025.
Focus area: Provide innovative and cost-effective treatment options
Grant form: Project grant
Call opens: November 2025
Estimated budget: Approx. 35 million Euros
The potential research objectives for this call will be as outlined in the EUP OHAMR Strategic Research and Innovation Agenda:
To develop new antimicrobials, novel treatment protocols or alternative treatment strategies against Human Infectious diseases along with their respective diagnostics.
To improve, preserve and reinforce the clinical efficacy of the current treatment antimicrobials.
Identification of barriers to access, availability, quality and uptake of therapeutic solutions and development of solutions to overcome those barriers.
Assessment and prediction of the impact of economic incentives and regulations on drug development, drug production, drug supply and treatment availability.
Participating countries
Austria, Belgium, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey and United Kingdom
Financement
Aucune information sur le financement n'a été fourni.
Pour postuler
Les instructions pour postuler n'ont pas encore été fournies.
Requis d'admission
Les critères d'admission n'ont pas encore été spécifiés.
Zones géographiques
Les zones géographiques n'ont pas encore été spécifiées.